Dapoxetine hydrochloride

PreclinicalSmall molecule

Dapoxetine hydrochloride is one of 9 small molecule programs targeting Premature Ejaculation. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Premature EjaculationActive, not recruiting

Premature EjaculationPreclinical

Active, not recruiting

Competition

Competitive Landscape

11 competitors in Premature Ejaculation

#DrugCompanyPhaseTrials

Xylocaine

MMEDRx USA, Inc.

Approved

1 2

Viagra

VViatris Specialty LLC

Approved

1 3

Botox

AbbVie

Phase 3

1 4

Standard Treatment

Boehringer Ingelheim

Phase 3

1 5

BP1.4979

BBioprojet

Phase 2

1 6

Botox

RRevance Therapeutics, Inc.

Preclinical

1 7

Bont-a

SSir Run Run Shaw Hospital

Preclinical

1 8

Dapoxetine hydrochloride

Johnson & Johnson

Preclinical

2 9

Serotonin Reuptake Inhibitor (SSRI)

MMedipol University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Premature Ejaculation2 trials

An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride

Completed· Johnson & Johnson logo

Johnson & Johnson··NCT01021670·10,027 enrolled

Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients

Unknown status·XXidian University·N/A·NCT03583112·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Dapoxetine hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dapoxetine hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dapoxetine hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Johnson & Johnson company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Johnson & Johnson

Dapoxetine hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Premature Ejaculation2 trials

References

Drug Info

Quick Facts

Related News